VNDA Operating Income Growth
Vanda Pharmaceuticals Inc · Operating Income Growth
VNDA Operating Income Growth
Year-over-year change vs the same period a year earlier
Latest reported-77.96%period ending
VNDA TTM Operating Income YoY % (-170.55% → -77.96%)
Year-over-year change
High-resolution chart · PNG
VNDA operating income growth history
Trailing twelve months (TTM). Each value covers four complete reported quarters.
| Period ending | Operating Income Growth |
|---|---|
| -77.9624% | |
| -111.0775% | |
| -280.4452% | |
| -232.5284% | |
| -221.3151% | |
| -201.5918% | |
| -191.4278% | |
| -16,264.6288% | |
| -435.6419% | |
| -257.4241% | |
| -320.4456% | |
| -102.7471% | |
| -36.5515% | |
| -33.7528% | |
| -84.9899% | |
| -81.0459% | |
| -62.724% | |
| -35.9369% | |
| 54.7964% | |
| 109.1199% | |
| 70.089% | |
| 52.2081% | |
| 19.4169% | |
| -24.1224% | |
| 3.6954% | |
| 43.9479% | |
| 4.9315% | |
| 165.5394% | |
| 3,329.9443% | |
| 362.5324% | |
| 228.6044% | |
| 167.7484% | |
| 93.553% | |
| 53.1853% | |
| 8.9817% | |
| 53.0418% | |
| 73.2913% | |
| 66.9507% | |
| 53.7862% | |
| -173.8947% | |
| -179.4338% | |
| -216.5658% | |
| -300.314% | |
| 177.49% | |
| 185.6961% | |
| 185.002% | |
| 198.3382% | |
| -199.0397% | |
| -219.858% | |
| -77.2247% | |
| 27.7236% | |
| 30.8392% | |
| 25.2002% | |
| -26.7774% | |
| -163.6126% | |
| -591.202% | |
| -89,868.9422% | |
| -805.4486% | |
| -221.1473% | |
| -235.4565% | |
| 100.2948% | |
| 111.6064% | |
| 124.5856% | |
| 96.5226% | |
| 74.42% | |
| 40.9178% | |
| 31.9749% | |
| 48.8973% | |
| 52.4705% | |
| 52.758% | |
| 33.9753% | |
| 4.4885% | |
| -33.316% | |
| -29.872% | |
| -21.8084% | |
| -16.6317% | |
| -11.957% | |
| -74.4183% | |
| -170.5537% |